Impact Biomedical Inc. SEC filings IBO
Impact Biomedical Inc. has 146 filings in SEC EDGAR's recent list, going back to Feb 12, 2021. Its latest annual report, Form 10-K, was filed on Mar 11, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 POS | Filing | Apr 22, 2026 | — |
| S-8 POS | Filing | Apr 6, 2026 | — |
| S-8 | Employee stock plan registration | Jan 24, 2025 | — |
| 424B4 | Prospectus | Sep 17, 2024 | — |
| S-1/A | Amended registration statement | Aug 27, 2024 | — |
| S-1/A | Amended registration statement | Aug 20, 2024 | — |
| S-1/A | Amended registration statement | Aug 9, 2024 | — |
| S-1/A | Amended registration statement | Jun 11, 2024 | — |
| S-1/A | Amended registration statement | Feb 28, 2024 | — |
| S-1/A | Amended registration statement | Nov 21, 2023 | — |
| S-1/A | Amended registration statement | Nov 1, 2023 | — |
| S-1 | Registration statement | Oct 17, 2023 | — |
| S-1/A | Amended registration statement | Aug 1, 2023 | — |
| S-1/A | Amended registration statement | Jul 24, 2023 | — |
| S-1/A | Amended registration statement | Jun 30, 2023 | — |
| S-1/A | Amended registration statement | Jun 21, 2023 | — |
| S-1/A | Amended registration statement | Jun 2, 2023 | — |
| S-1/A | Amended registration statement | May 15, 2023 | — |
| S-1/A | Amended registration statement | Jan 31, 2023 | — |
| S-1/A | Amended registration statement | Jan 9, 2023 | — |
| S-1/A | Amended registration statement | Dec 7, 2022 | — |
| S-1/A | Amended registration statement | Aug 24, 2022 | — |
| S-1/A | Amended registration statement | Aug 2, 2022 | — |
| S-1/A | Amended registration statement | Jul 11, 2022 | — |
| S-1/A | Amended registration statement | Jun 24, 2022 | — |
| S-1/A | Amended registration statement | Sep 29, 2021 | — |
| S-1 | Registration statement | Feb 12, 2021 | — |
Showing 27 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IBO (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- West Henrietta, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1834105
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.